Related Experiment Videos
Selegiline and Parkinson's disease. Protective and symptomatic considerations
L I Golbe1, J W Langston, I Shoulson
1University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick.
Drugs
|May 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.
Movement disorders : official journal of the Movement Disorder Society·2017
HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD).
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2016
Plasma 8-hydroxy-2'-deoxyguanosine Levels in Huntington Disease and Healthy Controls Treated with Coenzyme Q10.
Journal of Huntington's disease·2014
Baxdrostat: First Approval.
Drugs·2026
Andamertinib: First Approval.
Drugs·2026
Cefepime/Zidebactam: First Approval.
Drugs·2026
Acute Fulminant Demyelination after the COVID-19 Vaccine: A Case Report and Review of the Literature.
Case reports in neurology·2026
Repositioning Primary Health Care in Sierra Leone: From Geographic Access to Effective Coverage.
Annals of global health·2026